Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Influenza is a respiratory disease with high epidemic behavior; the main etiologic agents are influenza viruses A and B. The virus
influenza A are primarily responsible for annual epidemics and the only causing pandemics. Fighting these viral agents is based
mainly in the use of vaccines and drugs that inhibit viral proteins M2 and NA. Currently, the use of antiviral drugs has been limited
by the emergency and circulation of influenza virus variants resistant to adamantane worldwide. The neuraminidase inhibitors have
been the drug of choice available for the treatment and prophylaxis of influenza virus before the availability of influenza vaccine. The
aim of this work was the molecular characterization of influenza virus circulating in Cuba in the period April 2009-August 2010.
Phylogenetic analysis of seasonal influenza viruses and pandemic virus showed that both viruses were genetically similar to the
strains included in the vaccine recommended by �WHO�. Molecular characterization of these agents circulating in Cuba showed the
necessity of systematic monitoring of these Cuban genetic variants. In the present work we identified genetic variants of influenza A
resistant to oseltamivir. It was detected for the first time in Cuba the circulation of influenza A (H1N1) viruses with resistant markers
to the antiviral drugs available.